Non-Sedating Anti-Itch Options
For daytime pruritus management, use cetirizine 10 mg or loratadine 10 mg daily, or fexofenadine 180 mg daily as first-line non-sedating antihistamines. 1
First-Line Non-Sedating Oral Antihistamines
The following H1 antihistamines provide effective itch relief without significant sedation:
- Fexofenadine 180 mg once daily - truly non-sedating option recommended for generalized pruritus 1
- Loratadine 10 mg once daily - non-sedating with once-daily dosing 1
- Cetirizine 10 mg once daily - classified as "mildly sedative" but generally well-tolerated for daytime use 1
- Desloratadine - longest elimination half-life (27 hours), requires discontinuation 6 days before skin testing 1
- Levocetirizine - active enantiomer of cetirizine with similar profile 1
Dosing Strategy
Offer patients a choice of at least two different non-sedating antihistamines, as individual responses vary significantly. 1
- Start with standard manufacturer-recommended doses 1
- If inadequate response after trial period, consider increasing doses above licensed recommendations when benefits outweigh risks 1
- Adjust timing of medication to ensure peak drug levels coincide with anticipated worst itch periods 1
Combination Therapy for Refractory Cases
When monotherapy fails:
- Add H2 antagonist (cimetidine) to H1 antihistamine (fexofenadine) for enhanced effect through dual receptor blockade 1
- This combination approach targets different histamine receptor pathways simultaneously 1
Topical Non-Sedating Options
For localized pruritus without systemic therapy:
- Menthol 1% in aqueous cream - cooling antipruritic effect 1
- Topical clobetasone butyrate - mild corticosteroid for inflammatory component 1
- Emollients with high lipid content - particularly beneficial in elderly patients 1
Avoid topical doxepin for more than 8 days or on >10% body surface area, as systemic absorption can cause sedation. 1
Alternative Non-Antihistamine Options
For pruritus unresponsive to antihistamines:
- Gabapentin 100-300 mg three times daily - particularly effective for neuropathic itch and elderly patients 1
- Pregabalin - GABA agonist for severe, constant pruritus 1
- Paroxetine or fluvoxamine - SSRIs with antipruritic properties 1
- Mirtazapine - antidepressant with antihistaminic effects without significant daytime sedation 1
Clinical Context Considerations
The British Association of Dermatologists explicitly recommends against sedative antihistamines in elderly patients with pruritus due to cognitive impairment risk. 1
- Non-sedating antihistamines are preferred for urticaria where histamine is the primary mediator 1, 2
- For eczema, antihistamines provide limited benefit as itch is not primarily histamine-mediated, though they remain safe 3
- Cetirizine has the shortest time to maximum concentration, advantageous when rapid effect is needed 1
Important Caveats
- Mizolastine is contraindicated with cardiac disease, QT prolongation, or concurrent use of CYP450 inhibitors (macrolides, azole antifungals) 1
- Acrivastine requires three-times-daily dosing due to short half-life, limiting compliance 1
- Evidence for antihistamine efficacy in chronic pruritus is moderate quality at best, with individual response variation 1, 3
- Reserve sedating antihistamines (hydroxyzine) exclusively for nighttime use when sleep disruption is the primary concern 1, 4